111 related articles for article (PubMed ID: 6765062)
21. Pergolide compared with bromocriptine in Parkinson's disease: a multicenter, crossover, controlled study.
Pezzoli G; Martignoni E; Pacchetti C; Angeleri VA; Lamberti P; Muratorio A; Bonuccelli U; De Mari M; Foschi N; Cossutta E
Mov Disord; 1994 Jul; 9(4):431-6. PubMed ID: 7969210
[TBL] [Abstract][Full Text] [Related]
22. [Neurologic indications for bromocriptine (in addition to Parkinson's disease)].
Destee A
LARC Med; 1984 Feb; 4(2):107-11. PubMed ID: 6232436
[No Abstract] [Full Text] [Related]
23. [Dopamine-receptor stimulants in the treatment of Parkinson's disease (author's transl)].
Ringwald E; Hirt D; Markstein R; Vigouret JM
Nervenarzt; 1982 Feb; 53(2):67-71. PubMed ID: 7063089
[No Abstract] [Full Text] [Related]
24. [Improved therapeutic response to L-dopa in Parkinson's disease, when combined with bromocriptine (author's transl)].
Ulm G
Nervenarzt; 1981 Feb; 52(2):116-20. PubMed ID: 7219619
[No Abstract] [Full Text] [Related]
25. [Long-term results of treatment of Parkinson's disease with bromocriptine and domperidone (author's transl)].
Agid Y; Quinn N; Lhermitte F
Rev Neurol (Paris); 1981; 137(1):49-51. PubMed ID: 7232966
[TBL] [Abstract][Full Text] [Related]
26. Bromocriptine mesylate in Parkinson's disease.
Lieberman A; Kupersmith M; Neophytides A; Casson I; Durso R; Foo SH; Khayali M; Tartaro T
N Y State J Med; 1979 Oct; 79(11):1689-92. PubMed ID: 290866
[No Abstract] [Full Text] [Related]
27. The effect of deprenyl and levodopa on the progression of Parkinson's disease.
Olanow CW; Hauser RA; Gauger L; Malapira T; Koller W; Hubble J; Bushenbark K; Lilienfeld D; Esterlitz J
Ann Neurol; 1995 Nov; 38(5):771-7. PubMed ID: 7486869
[TBL] [Abstract][Full Text] [Related]
28. Early combination therapy with bromocriptine and levodopa in Parkinson's disease.
Factor SA; Weiner WJ
Mov Disord; 1993 Jul; 8(3):257-62. PubMed ID: 8341289
[TBL] [Abstract][Full Text] [Related]
29. Low-dose bromocriptine therapy in Parkinson's disease: double-blind, placebo-controlled study.
Staal-Schreinemachers AL; Wesseling H; Kamphuis DJ; vd Burg W; Lakke JP
Neurology; 1986 Feb; 36(2):291-3. PubMed ID: 3511405
[TBL] [Abstract][Full Text] [Related]
30. Bromocriptine in Parkinson's disease: report on 106 patients treated for up to 5 years.
Lieberman AN; Kupersmith M; Neophytides A; Gopinathan G; Casson I; Durso R; Foo SH; Khayali M; Tartaro T; Goldstein M
Adv Biochem Psychopharmacol; 1980; 23():245-53. PubMed ID: 7395614
[No Abstract] [Full Text] [Related]
31. [Parlodel: a new therapeutic possibility in the management of Parkinson disease].
Glaub T; Berecz G; Pintér N; Diószeghy P; Virga A; Mechler F
Orv Hetil; 1988 Feb; 129(8):399-402. PubMed ID: 3279375
[No Abstract] [Full Text] [Related]
32. Tolbutamde in the treatment of Parkinson's disease--a double blind trial.
Hansen JM; Kristensen M
Dan Med Bull; 1965 Dec; 12(7):181-4. PubMed ID: 5324060
[No Abstract] [Full Text] [Related]
33. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
Prescrire Int; 2005 Apr; 14(76):51-4. PubMed ID: 15875340
[TBL] [Abstract][Full Text] [Related]
34. Ropinirole as an adjunct to levodopa in the treatment of Parkinson's disease: a 16-week bromocriptine controlled study.
Im JH; Ha JH; Cho IS; Lee MC
J Neurol; 2003 Jan; 250(1):90-6. PubMed ID: 12527999
[TBL] [Abstract][Full Text] [Related]
35. [Pathological gambling behavior in a patient with Parkinson's disease treated with levodopa and bromocriptine].
Montastruc JL; Schmitt L; Bagheri H
Rev Neurol (Paris); 2003 Apr; 159(4):441-3. PubMed ID: 12773874
[TBL] [Abstract][Full Text] [Related]
36. [Treatment of Parkinson disease by bromocriptine in the black African].
Ndiaye IP; Jacquin-Cotton L; Martini L
Dakar Med; 1980; 25(2):131-5. PubMed ID: 7215100
[No Abstract] [Full Text] [Related]
37. Further experiences with low doses of bromocriptine in Parkinson's disease.
Fahn S; Côté LJ; Barrett RE; Snider SR
Adv Biochem Psychopharmacol; 1980; 23():255-60. PubMed ID: 7395615
[No Abstract] [Full Text] [Related]
38. Parkinson's disease: a comparison of mesulergine and bromocriptine.
Burton K; Larsen TA; Robinson RG; Bratty PJ; Martin WR; Schulzer M; Calne DB
Neurology; 1985 Aug; 35(8):1205-8. PubMed ID: 3895033
[TBL] [Abstract][Full Text] [Related]
39. [A comparative study of the effect of bromocriptine and pergolide on Parkinson disease].
de Yébenes JG; García-Ruiz PJ; Sánchez-Pernaute R
Rev Neurol; 1997 Sep; 25(145):1343-5. PubMed ID: 9377286
[TBL] [Abstract][Full Text] [Related]
40. Bromocriptine and Parkinson's disease: a 16-hour clinical evaluation.
Grøn U; Friis ML; Pakkenberg H
Acta Neurol Scand; 1980 Feb; 61(2):131-6. PubMed ID: 6994422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
